Elevance Health, Inc. $ELV Shares Bought by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lifted its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 8.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,820 shares of the company’s stock after acquiring an additional 4,711 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Elevance Health were worth $22,372,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in ELV. Rossby Financial LCC increased its holdings in Elevance Health by 110.0% in the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after purchasing an additional 44 shares in the last quarter. J.Safra Asset Management Corp acquired a new stake in shares of Elevance Health in the fourth quarter valued at about $32,000. ORG Partners LLC raised its holdings in shares of Elevance Health by 120.4% during the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after buying an additional 59 shares during the period. Dorato Capital Management purchased a new stake in shares of Elevance Health during the 4th quarter valued at about $41,000. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in Elevance Health during the 4th quarter worth approximately $38,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ELV has been the subject of several recent research reports. Robert W. Baird increased their price objective on shares of Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a research report on Thursday, April 23rd. Citigroup raised shares of Elevance Health to a “buy” rating in a research report on Wednesday, April 29th. The Goldman Sachs Group lifted their target price on Elevance Health from $350.00 to $370.00 and gave the stock a “neutral” rating in a research report on Friday, April 24th. Mizuho boosted their price target on Elevance Health from $435.00 to $465.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Truist Financial increased their price target on Elevance Health from $375.00 to $450.00 and gave the company a “buy” rating in a report on Monday, June 1st. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Elevance Health presently has a consensus rating of “Moderate Buy” and an average price target of $416.11.

Elevance Health Stock Performance

Shares of Elevance Health stock opened at $404.33 on Thursday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $426.98. The firm’s 50-day simple moving average is $362.40 and its 200-day simple moving average is $343.89. The firm has a market cap of $87.81 billion, a PE ratio of 17.20, a price-to-earnings-growth ratio of 2.40 and a beta of 0.67.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, beating the consensus estimate of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The firm had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. During the same period in the previous year, the company earned $11.97 earnings per share. Elevance Health’s quarterly revenue was up 1.5% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities analysts forecast that Elevance Health, Inc. will post 26.94 earnings per share for the current fiscal year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s payout ratio is 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.